Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK

Pantelis Samartsidis; Ross J Harris; Jessica Dillon; John Dillon; Monica Desai; Graham R Foster; Rory Gunson; Samreen Ijaz; Sema Mandal; Andrew Mcauley; Andrew T McAuley; Norah Palmateer; Norah E Palmateer; Anne M Presanis; Ruth Simmons; Shanley Smith; Beth Thorne; Alan Yeung; Mounia Zaouche; Sharon Hutchinson; Matthew Hickman; Daniela De Angelis

doi:10.1016/j.drugpo.2024.104429

Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK

Bibliographic Data

ID	14905609
Authors	Pantelis Samartsidis (0000-0002-4491-9655, University of Cambridge, corresponding author), Ross J Harris (UK Health Security Agency), Jessica Dillon (0000-0002-2164-4476, University of Dundee), John Dillon (0000-0002-2873-1249), Monica Desai (0000-0001-8632-9808, UK Health Security Agency), Graham R Foster (0000-0002-3704-386X, Queen Mary University of London), Rory Gunson (0000-0001-9163-492X), Samreen Ijaz (0000-0001-6658-3542, UK Health Security Agency), Sema Mandal (0000-0003-3379-3118, UK Health Security Agency), Andrew Mcauley (0000-0002-6047-2400), Andrew T McAuley (Glasgow Caledonian University), Norah Palmateer, Norah E Palmateer (0000-0003-4493-0173, Glasgow Caledonian University), Anne M Presanis (0000-0003-3078-4427, University of Cambridge), Ruth Simmons (0000-0001-8156-0146, UK Health Security Agency), Shanley Smith (0000-0002-9325-7619, Glasgow Caledonian University), Beth Thorne (University of Bristol), Alan Yeung (0000-0001-5226-3695, Glasgow Caledonian University), Mounia Zaouche (University of Cambridge), Sharon Hutchinson (0000-0002-6891-6758, Glasgow Caledonian University), Matthew Hickman (0000-0001-9864-459X, University of Bristol), Daniela De Angelis (0000-0001-6619-6112, University of Cambridge)
Year	2025
Volume	144
Issue	Pt 1
Pages	104429
Publication date	2025-10-01
Open Access	Yes
Type	ARTICLE
Venue	International Journal of Drug Policy (JOURNAL)
Journal identifiers	ISSN: 0955-3959 • E-ISSN: 1873-4758
Publisher	Elsevier BV (PUBLISHER)
DOI	10.1016/j.drugpo.2024.104429
PMID	38942687
OpenAlex	W4400071055
Language	EN
References cited	51

Real-world evidence showing substantial reductions in chronic HCV associated with increase of HCV treatment scale-up in the community thus supporting the effectiveness of HCV treatment as prevention in people who inject drugs

Environmental health · Logistic regression · Demography · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Internal Medicine

Tools

Open DOIOpen Access

Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK

Bibliographic Data

Counterfactuals and Causal Inference

Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs

Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs

Burden of liver diseases in the world

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs

Hepatitis C virus treatment for prevention among people who inject drugs

Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs

Tools